Magnus Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Magnus Financial Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,073	Closed	-$255K	–	291
2022 Q4	$255K	Buy	3,073 +110	+4%	+$8.91K	0.04%	220
2022 Q3	$235K	Sell	2,963 -3,833	-56%	-$323K	0.04%	215
2022 Q2	$505K	Sell	6,796 -1,811	-21%	-$136K	0.09%	146
2022 Q1	$774K	Buy	8,607 +6,620	+333%	+$611K	0.13%	127
2021 Q4	$222K	Sell	1,987 -5,455	-73%	-$658K	0.04%	230
2021 Q3	$936K	Buy	7,442 +155	+2%	+$20K	0.2%	74
2021 Q2	$987K	Buy	7,287 +2,289	+46%	+$301K	0.22%	72
2021 Q1	$678K	Buy	4,998 +515	+11%	+$77.1K	0.16%	86
2020 Q4	$631K	Buy	4,483 +165	+4%	+$21.1K	0.06%	118
2020 Q3	$481K	Buy	4,318 +1,695	+65%	+$190K	0.06%	131
2020 Q2	$294K	Buy	+2,623	New	+$258K	0.03%	363

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Magnus Financial Group's XBI Position: Q1 2023 in Review

Magnus Financial Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 3,073 shares — an estimated $255K sold.

Magnus Financial Group first reported a position in XBI in Q2 2020 and held it in 11 quarters. The position peaked at $987K in Q2 2021. 712 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

Magnus Financial Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
Magnus Financial Group sold 3,073 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $255K.
Magnus Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 11 quarters.
Magnus Financial Group's State Street SPDR S&P Biotech ETF position peaked at $987K in Q2 2021.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Magnus Financial Group's 13F filing for Q1 2023, filed 10 May 2023.